Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124723565 | 12472356 | 5 | F | 20160505 | 20160824 | 20160616 | 20160831 | EXP | CA-SEATTLE GENETICS-2016SGN00722 | SEATTLE GENETICS | 0.00 | Y | 0.00000 | 20160831 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124723565 | 12472356 | 1 | PS | PLACEBO FOR BRENTUXIMAB VEDOTIN | BRENTUXIMAB VEDOTIN | 1 | Intravenous (not otherwise specified) | 1.8 MG/KG, Q3WEEKS | U | 125388 | 1.8 | MG/KG | INJECTION | Q3W | |||||
| 124723565 | 12472356 | 2 | SS | Vincristine | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 1.4 MG/M2, Q3WEEKS | U | 0 | 1.4 | MG/M**2 | Q3W | ||||||
| 124723565 | 12472356 | 3 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 750 MG/M2, Q3WEEKS | U | 0 | 750 | MG/M**2 | INJECTION | Q3W | |||||
| 124723565 | 12472356 | 4 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 50 MG/M2, Q3WEEKS | U | 0 | 50 | MG/M**2 | INJECTION | Q3W | |||||
| 124723565 | 12472356 | 5 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 100 MG, QCYCLE | U | 0 | 100 | MG | /cycle | ||||||
| 124723565 | 12472356 | 6 | C | RAMIPRIL. | RAMIPRIL | 1 | UNK | 0 | |||||||||||
| 124723565 | 12472356 | 7 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | UNK | 0 | |||||||||||
| 124723565 | 12472356 | 8 | C | SIMVASTATIN. | SIMVASTATIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124723565 | 12472356 | 1 | Peripheral T-cell lymphoma unspecified |
| 124723565 | 12472356 | 2 | Peripheral T-cell lymphoma unspecified |
| 124723565 | 12472356 | 3 | Peripheral T-cell lymphoma unspecified |
| 124723565 | 12472356 | 4 | Peripheral T-cell lymphoma unspecified |
| 124723565 | 12472356 | 5 | Peripheral T-cell lymphoma unspecified |
| 124723565 | 12472356 | 6 | Hypertension |
| 124723565 | 12472356 | 7 | Coronary artery disease |
| 124723565 | 12472356 | 8 | Coronary artery disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124723565 | 12472356 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124723565 | 12472356 | Febrile neutropenia | |
| 124723565 | 12472356 | Gastric ulcer | |
| 124723565 | 12472356 | Groin abscess |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124723565 | 12472356 | 1 | 20160429 | 20160429 | 0 | |
| 124723565 | 12472356 | 2 | 20160429 | 20160429 | 0 | |
| 124723565 | 12472356 | 3 | 20160429 | 20160429 | 0 | |
| 124723565 | 12472356 | 4 | 20160429 | 20160429 | 0 | |
| 124723565 | 12472356 | 5 | 20160429 | 20160503 | 0 | |
| 124723565 | 12472356 | 6 | 2015 | 0 | ||
| 124723565 | 12472356 | 7 | 2015 | 0 | ||
| 124723565 | 12472356 | 8 | 2015 | 0 |